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Aims:  Portugal  has  one  of  the  lowest  rates  of  primary  percutaneous  coronary  intervention
(p-PCI) in  Western  Europe.  This  study  assessed  the  progress  of  Portuguese  p-PCI  performance
indicators  one  year  after  Portugal  joined  the  Stent  for  Life  (SFL)  initiative.
Methods and  Results: Two  national  surveys  were  carried  out,  each  covering  a  period  of  one
month: the  first  when  Portugal  joined  the  SFL  in  2011  (Moment  Zero),  and  the  second  one
year later  (Moment  One).  A  total  of  397  consecutive  patients  with  probable  ST-segment  eleva-
tion myocardial  infarction  were  enrolled  (201  at  Moment  Zero  and  196  at  Moment  One)  from
15 centers.  During  this  period,  the  number  of  patients  who  arrived  at  a  local  hospital  with-
out p-PCI  decreased  (62--47%;  p=0.004)  and  transportation  to  a  p-PCI  hospital  by  the  National
Institute for  Medical  Emergencies  (INEM)  increased  significantly  (13--37%;  p<0.001).  Shorter
times to  revascularization  were  observed,  due  to  shorter  patient  delay  (118--102  min;  p=0.008).
Door-to-balloon  delay  and  system  delay  remained  unchanged.
Conclusions:  Improvements  in  performance  indicators  for  p-PCI  demonstrate  the  success  of  the
first year  of  the  local  SFL  plan,  which  was  mainly  focused  on  raising  public  awareness  of
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the need  to  use  the  INEM  emergency  services,  which  has  reduced  patient  delay,  and  on  improving
secondary  transportation.
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Stent  for  Life  em  Portugal:  uma  iniciativa  para  ficar
Resumo
Objetivo:  Portugal  é  um  dos  países  europeus  que  apresenta  uma  das  mais  baixas  taxas  de
angioplastia  primária  (p-PCI).  O  objetivo  deste  estudo  foi  avaliar  os  indicadores  de  performance,
em termos  de  p-PCI,  um  ano  após  Portugal  ter  integrado  a  Iniciativa  Stent  for  Life  (SFL).
Métodos  e  resultados:  foram  efetuados  dois  inquéritos  nacionais,  com  a  duração  de  um  mês,  o
primeiro  em  2011,  no  momento  inicial  de  integração  do  projecto  SFL  em  Portugal  («Momento
Zero») e  o  segundo  em  2012  após  um  ano  de  atuação  («Momento  Um»).  Foram  incluídos  397
doentes consecutivos  submetidos  a  cateterismo  por  suspeita  de  enfarte  agudo  do  miocárdio  com
supradesnivelamento  de  ST  (EMSST),  em  15  centros  nacionais  de  cardiologia  de  intervenção
(201 Momento  Zero,  196  Momento  Um).  Ocorreu  uma  redução  significativa  dos  doentes  que
recorreram  a  centros  sem  cardiologia  de  intervenção  (62%  versus  47%,  p=0,004)  e  aumentou
o transporte  dos  doentes  pelo  sistema  nacional  de  emergência  médica  (INEM)  para  um  centro
com ICP  primária  (13%  versus  37%,  p<0,001).  A  principal  melhoria  observada  nos  intervalos  de
tempo para  a  revascularização,  foi  no  «atraso  do  doente» (118  minutos  no  «Momento  Zero»
diminuiu  para  102  minutos  no  «Momento  Um», p=0,008).  O  «tempo  porta-balão» manteve-se
constante.
Conclusão:  a  melhoria  dos  indicadores  de  desempenho  da  rede  nacional  de  tratamento  do
enfarte do  miocárdio  com  supradesnivelamento  de  ST  aponta  para  o  sucesso  do  plano  de  ação  da
Iniciativa Stent  for  Life,  que  neste  primeiro  ano  se  centrou  na  sensibilização  da  população  para
recurso ao  INEM  em  caso  de  suspeita  de  enfarte,  e  na  realização  do  transporte  interhospitalar
por esta  instituição.
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ESC  European  Society  of  Cardiology
FMC  first  medical  contact
INEM  National  Institute  for  Medical  Emergencies
MI  myocardial  infarction
p-PCI  primary  percutaneous  coronary  intervention
SFL  Stent  for  Life
STEMI  ST-segment  elevation  myocardial  infarction
ntroduction
he  Stent  for  Life  (SFL)  initiative  aims  to  improve  the  deliv-
ry  of  facilities  that  will  reduce  mortality  and  morbidity  in
atients  with  ST-segment  elevation  myocardial  infarction
STEMI),  by  increasing  timely  access  to  primary  percuta-
eous  coronary  intervention  (p-PCI).1,2 A  2010  study  that
ompared  how  patients  with  STEMI  were  treated  in  differ-
nt  European  countries  reported  that  there  was  a  low  rate
f  p-PCI  in  Portugal,  as  well  as  a  high  proportion  of  patientsPlease  cite  this  article  in  press  as:  Pereira  H,  et  al.  Stent  for
Cardiol.  2014.  http://dx.doi.org/10.1016/j.repc.2014.02.013
ho  did  not  receive  any  reperfusion  therapy.3
Several  countries  participating  in  the  SFL  initiative  have
eported  encouraging  results,  with  a  significant  increase  in




f  the  latest  countries  to  join  SFL,  in  February  2011,  and
 local  action  program  has  been  implemented  to  increase
atient  access  to  p-PCI  and  to  improve  its  quality,  mainly  by
educing  the  time  between  symptom  onset  and  p-PCI.
The  SFL  Portugal  initiative  implemented  a  national  survey
o  characterize  STEMI  treatment  that  included  all  centers
n  the  Portuguese  mainland  with  an  interventional  cardiol-
gy  unit  available  24/7  and  which  followed  p-PCI  protocols.
 prospective  registry  was  set  up  for  one  month,  from  May  9
o  June  8,  2011  (‘‘Moment  Zero’’).12 This  study  revealed  that
he  time  between  symptom  onset  and  first  medical  contact
FMC)  was  too  long,  and  that  only  one-third  of  patients
equested  medical  assistance  from  the  Portuguese  emer-
ency  medical  system,  the  National  Institute  for  Medical
mergencies  (INEM).  Consequently,  more  than  half  of  the
atients  attended  local  hospitals  without  interventional  car-
iology  units.
The  SFL  Portugal  Task  Force  set  out  an  action  plan  with
hree  main  aims:  (1)  to  launch  a  national  public  campaign
o  raise  public  awareness  of  the  symptoms  of  myocardial
nfarction  (MI)  and  of  the  actions  that  should  be  taken  to
nsure  timely  and  appropriate  treatment;  (2)  to  cooperate
ith  INEM  to  improve  patient  routing,  by  enabling  direct
dmission  to  a  hospital  with  p-PCI  facilities  (‘‘p-PCI  hos-
ital’’)  and  transfer  from  hospitals  without  interventional
ardiology  units  to  a  p-PCI  hospital;  (3)  to  improve  hospital
erformance  in  the  treatment  of  STEMI  by  p-PCI. Life  in  Portugal:  This  initiative  is  here  to  stay.  Rev  Port
To  assess  the  impact  of  these  actions,  in  2012,  exactly
ne  year  after  the  Portugal  SFL  initiative  was  launched,  a
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Methods
Study  design  and  data  collection
A  national  survey  was  carried  out  in  15  centers  in  Portu-
gal  equipped  for  p-PCI,  with  an  interventional  cardiology
unit  available  24/7,  to  record  all  consecutive  catheterized
patients  with  a  presumed  diagnosis  of  STEMI  for  a  period
of  one  month  (May  9--June  8).  Patients  who  received  fib-
rinolytic  therapy  prior  to  being  transferred  from  another
hospital  were  excluded  from  the  study.
The  survey  was  carried  out  in  each  center  at  two  time
points:  the  first  immediately  after  Portugal  joined  the  SFL
initiative  (Moment  Zero),  and  the  second  one  year  later,  in
2012  (Moment  One).  The  patients’  demographic  variables
and  cardiovascular  history  were  recorded.
Data  collected  also  included  the  number  of  patients  who
used  the  national  medical  emergency  number  (112)  to  obtain
direct  assistance  from  INEM,  who  are  responsible  for  pre-
hospital  transportation.  The  type  of  FMC  was  registered,
as  well  as  the  transportation  used  to  attend  the  center  for
p-PCI.  It  was  also  recorded  whether  the  patient  attended
another  hospital  or  healthcare  facility  before  arriving  at  an
institution  with  p-PCI.
The  two  time  points  (Moment  Zero  and  Moment  One)
were  compared  in  terms  of  time  between  symptom  onset
and  p-PCI.
The  rates  of  timely  delivery  of  p-PCI  were  analyzed
according  to  the  guidelines  of  the  European  Society  of
Cardiology17:  the  recommended  time  between  FMC  and  the
first  electrocardiogram  (ECG)  should  be  ≤10  min,  and  from
FMC  to  p-PCI  should  be  ≤90  min.  However,  in  p-PCI  hospi-
tals,  door-to-balloon  (D2B)  time  (time  between  presentation
at  the  p-PCI  hospital  and  use  of  first  device  in  the  culprit
artery)  should  be  ≤60  min.
No  data  were  collected  regarding  the  clinical  outcomes
of  the  interventions  performed.
SFL  Task  Force  strategy  for  action
During  the  first  year  of  the  SFL  initiative  in  Portugal,  one
of  the  major  priorities  was  to  reduce  patient  delay  (time
between  symptom  onset  and  FMC),  by  raising  awareness  of
MI  symptoms  and  of  the  actions  that  should  be  taken  to
ensure  timely  and  appropriate  treatment,  especially  the  use
of  the  112  emergency  call  service.  To  achieve  this  goal,  a
national  public  campaign  with  the  slogan  ‘‘Não  perca  tempo.
Salve  uma  vida’’ (‘‘Act  now.  Save  a  life’’)  was  launched
in  December  2011.  SFL  partners  from  different  industries,
including  medical  devices,  pharmaceuticals,  energy  and
telecommunications,  helped  to  increase  the  visibility  of  the
campaign  in  the  media,  while  various  educational  activities,
such  as  distribution  of  leaflets  and  screening  for  cardiovas-
cular  disease,  were  also  carried  out  at  clinics  and  shopping
centers,  in  private  companies  and  in  the  Portuguese  Parlia-
ment.Please  cite  this  article  in  press  as:  Pereira  H,  et  al.  Stent  for
Cardiol.  2014.  http://dx.doi.org/10.1016/j.repc.2014.02.013
Time  measures
FMC  was  defined  as  the  time  at  which  medical  personnel,






he  patient,  or  the  time  of  arrival  at  a  hospital  equipped
or  fibrinolysis  or  p-PCI.  The  delays  between  symptom  onset
nd  p-PCI  were  defined  as:  (1)  patient  delay  --  the  time
etween  symptom  onset  and  FMC;  (2)  pre-hospital  trans-
ortation  delay  --  the  time  between  FMC  by  pre-hospital
aramedical  staff  and  hospital  attendance;  (3)  local  hos-
ital  delay  or  door-to-door  (D2D)  delay  --  the  time  between
ttendance  at  the  local  hospital  and  attendance  at  the  p-PCI
ospital;  (4)  door-to-balloon  (D2B)  delay  --  the  time  between
ttendance  at  the  p-PCI  hospital  and  use  of  first  device  in
he  culprit  artery;  (5)  system  delay  --  the  time  between
MC  and  reperfusion  therapy  (for  patients  who  go  directly
o  a p-PCI  hospital,  system  delay  corresponds  to  D2B,  while
or  others,  it  is  pre-hospital  transportation  delay  plus  D2B);
nd  (6)  treatment  delay  --  the  time  between  symptom  onset
nd  reperfusion  therapy,  corresponding  to  patient  delay  plus
ystem  delay.
tatistical  analysis
ontinuous  variables  were  expressed  as  mean  ±  standard
eviation,  except  time  intervals,  which  were  expressed  as
edian  and  interquartile  range.  Categorical  variables  were
ummarized  as  absolute  and  relative  frequency  distribu-
ions.  Independent  Student’s  t-tests  were  used  for  group
omparisons  of  continuous  variables,  while  the  chi-square
est  or  Fisher’s  exact  test  was  used  for  categorical  variables.
The  Mann--Whitney  nonparametric  test  was  used  to  com-
are  time  intervals  between  the  two  surveys  (Moment  Zero
s.  Moment  One).  All  tests  were  two-sided  and  assumed  a
ignificance  level  of  5%.  All  statistical  analyses  were  per-
ormed  using  SPSS  Statistics  for  Windows,  version  17.0  (SPSS
nc.,  Chicago,  USA).
esults
aseline  demographic  and  clinical  characteristics
f  the  19  centers  that  perform  p-PCI  in  mainland  Portugal,
5  participated  in  this  study  and  included  data  from  397
atients  (201  patients  assessed  and  treated  at  Moment  Zero
nd  196  at  Moment  One).
Table  1  presents  the  patients’  demographic  data  and  clin-
cal  background.  Mean  age  was  62  ±  13  years,  20%  were
emale  and  18%  presented  a  history  of  diabetes.  The  inci-
ence  of  a  history  of  cardiovascular  disease  was  low  and  did
ot  differ  significantly  between  groups.  A  diagnosis  of  STEMI
as  confirmed  in  92%  of  the  patients  (Table  2).
At  Moment  Zero,  only  33%  of  the  patients  used  the
ational  medical  emergency  number,  112,  to  call  for  assis-
ance.  During  this  first  year  the  main  goal  was  to  shorten
atient  delays.  At  Moment  One,  one  year  after  Portugal
oined  the  SFL  initiative,  an  improvement  of  5%  (not  sta-
istically  significant)  was  observed.  On  the  other  hand,  the
umber  of  patients  who  first  went  to  local  hospitals  without
-PCI  facilities  fell  significantly,  from  62%  to  47%  (p=0.004,
able  3). Life  in  Portugal:  This  initiative  is  here  to  stay.  Rev  Port
Regarding  transportation,  the  number  of  patients  trans-
orted  to  a  p-PCI  hospital  by  INEM  increased  significantly,
rom  13%  to  37%  between  Moment  Zero  and  Moment  One
p<0.001).  This  was  due  to  a  greater  number  of  patients
ARTICLE IN PRESS+ModelREPC-477; No. of Pages 8
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Table  1  Demographics  and  clinical  background.
Moment  Zero  Moment  One  p
(n=201) (n=196)
Age,  years  (mean  ±  SD)  62  ±  14  62  ±  13  0.73
Female, %  (n) 21.9  (44/201) 18.6  (35/188)  0.42
Diabetes, %  (n) 17.1  (32/187) 21.6  (41/190) 0.27
History of  CAD,  %  (n)
Previous  MI 9.0  (17/189) 11.1  (21/190) 0.51
Previous PCI  9.2  (18/195)  9.9  (19/191)  0.81
Previous CABG  1.0  (2/193)  1.1  (2/190)  1.00
CABG: coronary artery bypass graft; CAD: coronary artery disease; MI: myocardial infarction; PCI: percutaneous coronary intervention;
SD: standard deviation.
Table  2  Diagnosis  after  medical  team  activation,  %  (n).
Moment  Zero Moment  One p
(n=201)  (n=196)
STEMI  91.5  (184/201)  93.8  (183/195)  0.379
Coronary arteries  without  significant  lesions  4.5  (9/201)  3.1  (6/195)  0.465
Myopericarditis  1.5  (3/201)  1.0  (2/195)  1.000
Takotsubo cardiomyopathy  1.5  (3/201)  1.0  (2/195)  1.000
Medical team  activated  but  coronary  angiography
not  performed
1.0  (2/201)  0  0.499
STEMI: ST-elevation myocardial infarction.
Table  3  Means  of  transportation  to  a  p-PCI  hospital  and  treatment  delays.
Moment  Zero  Moment  One  p
(n=201)  (n=196)
Patients  who  contacted  INEM,  %  (n)  33.2  (64/193)  38.3  (75/196)  0.246
Arrival at  primary  care  center  before  FMC  22.4  (45/201)  9.7  (19/196)  0.001
Arrival at  hospitala without  p-PCI  61.7  (125/201)  47.4  (93/196)  0.004
Arrival at  hospital  with  p-PCI  via  INEM  13.3  (26/195)  36.9  (69/187)  <0.001
Treatment delays
Symptom  onset  to  FMC  118  [70,230]  102  [47,162]  0.008
Symptom onset  to  ECG  144  [84,260]  120  [67,202]  0.008
Symptom onset  to  LH  140  [84,270]  103  [52,160]  0.007
FMC to  ECG  17  [8,45]  15  [5,32]  0.057
FMC to  ECG  ≤10  min,  %  (n)  32.3  (54/167)  40.1  (71/177)  0.134
FMC to  p-PCI  hospital  104  [62,150]  88  [57,135]  0.258
D2B 55  [30,106]  53  [34,97]  0.886
D2B ≤60  min,  %  (n)  53.5  (91/170)  54.4  (87/160)  0.878
System delay  115  [79,177]  127  [92,189]  0.175
System delay  ≤90  min,  %  (n)  32.4  (55/170)  23.9  (38/159)  0.089
Treatment delay  262  [177,460]  250  [165,387]  0.216
Treatment delay  ≤120  min,  %  (n)  8.2  (14/170)  11.5  (19/165)  0.314
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at  Moment  One,  31%  of  patients  who  went  to  local  hospitals
ithout  p-PCI  facilities  were  transferred  by  INEM  to  a  p-PCI
enter).
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Figure  1  Treatment  delays  (in  min)  at  Moment  Zero  and  at
Moment  One.  D2B:  door-to  balloon  delay;  FMC-p-PCI  hospital:












Figure  3  Treatment  delays  (in  min)  of  patients  transported
by INEM  vs.  patients  transported  by  other  means  to  a  p-PCI  hos-
pital. FMC:  first  medical  contact;  INEM:  National  Institute  for
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Treatment  delays  in  the  general  population
One  year  after  the  SFL  initiative  was  launched  in  Por-
tugal,  the  main  positive  impact  was  observed  in  patient
delay,  which  had  decreased  significantly  by  Moment  One
(Table  3  and  Figure  1).  The  median  time  from  symptom
onset  to  ECG  and  from  symptom  onset  to  arrival  at  a  hos-
pital  without  p-PCI  also  decreased  between  Moment  Zero
and  Moment  One,  suggesting  that  patients  are  requesting
assistance  sooner.
In  both  groups,  84%  of  the  patients  reached  FMC  within
six  hours  of  symptom  onset.  The  number  of  patients
who  arrived  at  the  hospital  more  than  six  hours  after
symptom  onset  had  decreased  at  Moment  One  (17%  at
Moment  Zero  vs.  10%  at  Moment  One,  p=0.048).  At  the
same  time,  an  increase  was  observed  in  the  number  of
patients  arriving  at  the  hospital  within  30  minutes
of  symptom  onset  (9%  at  Moment  Zero  vs.  15%  at  Moment
One,  p=0.066)  and  within  one  hour  of  symptom  onset
(23%  at  Moment  Zero  vs.  35%  at  Moment  One,  p=0.007)
(Figure  2).
The  median  system  delay  at  Moment  One  was  127  minutes
(interquartile  range,  92--189),  not  significantly  differentPlease  cite  this  article  in  press  as:  Pereira  H,  et  al.  Stent  for
Cardiol.  2014.  http://dx.doi.org/10.1016/j.repc.2014.02.013
from  Moment  Zero.  The  median  treatment  delay  at  Moment
One  was  four  hours,  also  not  statistically  different  from  the
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Figure  2  Frequency  distribution  of  time  (in  min)  from  symp-

















ransported  by  means  other  than  INEM;  p-PCI:  primary  percuta-
eous coronary  intervention.
reatment  delay  in  patients  transported  to  p-PCI
ospitals by INEM
f  the  397  patients  enrolled  in  this  study,  95  were  trans-
orted  to  a p-PCI  hospital  by  INEM  (26  patients  at  Moment
ero  and  69  at  Moment  One).  At  both  points,  transportation
o  a  p-PCI  hospital  by  INEM  was  associated  with  signifi-
antly  shorter  treatment  delays,  compared  to  patients  who
rrived  at  p-PCI  hospitals  by  other  means.  Differences  were
bserved  in  patient  delay  (78  min  vs.  120  min,  p<0.001);  pre-
ospital  transportation  delay  (60  min  vs.  110  min,  p<0.001);
2B  delay  (42  min  vs.  63  min,  p=0.007);  and  treatment
elay  (211  min  vs.  267  min,  p=0.002).  Regarding  patients
ransported  by  INEM,  patient  delay  and  D2B  delay  did  not
iffer  significantly  between  Moment  Zero  and  Moment  One.
n  the  other  hand,  the  FMC  to  p-PCI  hospital  time  was
onger  at  Moment  One  than  at  Moment  Zero  in  this  subgroup
66  min  vs.  50  min,  p=0.044),  following  implementation
f  a  new  inter-hospital  transportation  system  by  INEM  at
oment  One  (Figure  3).  At  Moment  One,  the  D2D  delay  in  the
7  patients  transferred  by  INEM  to  a p-PCI  hospital  was  sig-
ificantly  longer  than  the  pre-hospital  transportation  delay
f  42  patients  directly  transported  by  INEM  to  a  p-PCI  hos-
ital  without  previously  attending  a  local  hospital  without
-PCI  (121  min  vs.  52  min;  p<0.001).
reatment  delay  in  patients  presenting  to  a  local
ospital without  p-PCI
verall,  55%  of  the  patients  attended  a  local  hospital  with-
ut  p-PCI  or  a  clinic  (125  patients  at  Moment  Zero  and
3  patients  at  Moment  One).  A  significantly  greater  treat-
ent  delay  was  observed  for  these  patients  (283  min  vs.
23  min  for  patients  arriving  directly  at  a  p-PCI  hospital,
<0.001).  D2B  time  was  shorter  in  patients  attending  a  local
ospital  and  transferred  after  diagnosis  to  a  p-PCI  hospi-
al  (36  min  vs.  84  min,  p<0.001)  compared  to  patients  who Life  in  Portugal:  This  initiative  is  here  to  stay.  Rev  Port
ent  directly  to  p-PCI  hospitals.  On  the  other  hand,  D2D
ime  was  considerably  longer  than  pre-hospital  transporta-
ion  time  (109  min  vs.  51  min,  p<0.001),  which  resulted  in
 significantly  greater  system  delay  in  patients  undergoing
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MC:  first  medical  contact;  LH:  local  hospital;  p-PCI:  primary
ercutaneous  coronary  intervention.
nter-hospital  transfer  (140  min  vs.  103  min,  p<0.001).
atient  transportation  time  to  p-PCI  hospitals  was  not  sta-
istically  different  between  Moment  Zero  and  Moment  One
Figure  4).
iscussion
ardiovascular  disease  is  the  leading  cause  of  mortality  in
urope.  MI,  stroke  and  other  cardiovascular  diseases  claim
ore  than  two  million  lives  per  year,  and  account  for  more
han  40%  of  all  deaths  in  the  region.13
The  SFL  initiative  was  launched  in  2008  by  the  European
ssociation  for  Percutaneous  Cardiovascular  Interventions
nd  EuroPCR  together  with  the  Working  Group  on  Acute
ardiac  Care  of  the  European  Society  of  Cardiology  (ESC)
nd  national  cardiology  societies  of  the  participating
ountries.1,2,4 The  SFL  initiative  is  a  three-year  project  aim-
ng  to  reduce  mortality  and  morbidity  in  patients  suffering
rom  STEMI  in  ESC  member  countries,  by  improving  patient
ccess  to  p-PCI.4
A  2008  study  of  Portuguese  performance  indicators
eported  that  only  19%  of  the  patients  received  p-PCI  and
 high  percentage  did  not  receive  any  revascularization
herapy.3 According  to  a  study  by  the  Portuguese  Cardiol-
gy  Society  (SPC)  based  on  the  Portuguese  Registry  of  Acute
oronary  Syndromes,  in  55%  of  the  STEMI  patients  who  did
ot  receive  any  form  of  revascularization  therapy,  the  rea-
on  was  hospital  arrival  more  than  12  hours  after  symptom
nset.14
For  these  reasons,  the  Portuguese  Association  of  Cardio-
ascular  Intervention  proposed  to  join  the  SFL  initiative,
hich  it  did  in  February  2011.
The  SFL  Portugal  constituted  a  Task  Force  that  defined
 three-year  action  plan,  with  three  major  aims:  (1)  to
ncrease  the  use  of  p-PCI  to  more  than  70%  of  STEMI  patients;
2)  to  achieve  p-PCI  rates  of  more  than  500  per  million  popu-
ation  per  year;  (3)  to  improve  the  network  of  p-PCI  centers
ffering  a  24/7  catheterization  service.
From  May  to  June  2011,  a  national  survey  was  carried
ut  for  one  month,  to  evaluate  performance  indicators  atPlease  cite  this  article  in  press  as:  Pereira  H,  et  al.  Stent  for
Cardiol.  2014.  http://dx.doi.org/10.1016/j.repc.2014.02.013
he  beginning  of  the  SFL  initiative  in  Portugal,  designated
oment  Zero.  The  results  from  this  first  survey  gave  an
p-to-date  picture  of  how  STEMI  patients  were  treated  in
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-PCI  program  in  Portugal  as  being  long  symptom  onset  to
MC  times,  the  low  number  of  patients  who  contacted  the
ational  medical  emergency  number  (112),  and  the  high
umber  of  patients  (more  than  half)  who  attended  centers
ithout  p-PCI  facilities.12
To  overcome  these  barriers,  the  SFL  Portugal  Task  Force
eveloped  an  action  plan  with  three  main  aims:  (1)  to
aunch  the  national  public  campaign  ‘‘Act  now.  Save  a  life’’,
n  order  to  raise  public  awareness  of  the  symptoms  of
I  and  to  encourage  people  to  call  the  national  medical
mergency  number  (112)  immediately;  (2)  to  collaborate
ith  INEM  to  improve  direct  communication  between  pre-
ospital  services  and  p-PCI  equipped  hospitals  and  to  provide
ransportation  from  hospitals  without  interventional  cardi-
logy  units  to  p-PCI  hospitals;  (3)  to  implement  a  national
lan  enabling  access  to  p-PCI  for  all  STEMI  patients,  through
NEM  and  its  operational  center,  the  Referral  Center  for
mergency  Patients  (CODU).
chievements  during  the  first  year  of  the  SFL
ortugal initiative
ction  1:  Educational  information  in  the  form  of  leaflets,
ins  and  posters  was  distributed  to  raise  public  awareness  of
I  symptoms  and  the  need  to  act  quickly  and  call  112.  A web-
ite  (www.stentforlife.pt) was  set  up  to  introduce  the  SFL
nitiative  and  its  work  in  Portugal.  SFL  partners  from  differ-
nt  industries,  including  medical  devices,  pharmaceuticals,
nergy  and  telecommunications,  have  helped  to  increase
he  visibility  of  the  campaign  in  the  media.  The  campaign
as  widely  covered  by  newspapers  (with  an  average  of  26
ews  segments  or  articles  per  month),  radio  and  TV  (with
ver  two  hours  of  coverage  on  three  national  television
hannels  in  eight  months).
Action  2:  During  the  first  year  of  the  SFL  Portugal  ini-
iative,  INEM  began  to  contact  cardiologists  operating  at
-PCI  hospitals  directly,  by  telephone.  In  addition,  all  INEM
mbulances  were  equipped  with  telemetry  and  facilities  to
ransfer  ECGs  to  p-PCI  hospitals.  In  most  cases,  this  enabled
atients  to  be  transferred  immediately  to  the  catheteriza-
ion  laboratory  without  first  passing  through  the  emergency
oom,  minimizing  delay.  Later,  a  new  inter-hospital  trans-
ortation  system  was  also  implemented;  during  2012,  INEM
egan  to  take  over  patient  transfer  from  local  hospitals  to
ospitals  with  interventional  cardiology  units,  which  will
oon  be  implemented  at  the  national  level.
Action  3:  According  to  the  Portuguese  Registry  of  Acute
oronary  Syndromes,  the  rate  of  fibrinolysis  has  decreased
ubstantially.  In  2011  only  7%  of  the  STEMI  patients  were
eperfused  by  fibrinolysis  and  25%  did  not  receive  any  form
f  revascularization.  No  studies  or  official  data  are  yet  avail-
ble,  but  based  on  information  from  countries  with  better
erformance  in  this  field,  we  estimate  that  a  substantial
umber  of  patients  do  not  receive  any  form  of  reperfusion
nd  some  patients  treated  by  fibrinolysis  could  have  been
reated  by  p-PCI  instead.  For  patients  treated  by  fibrinoly-
is,  it  is  not  known  whether  they  underwent  early  coronary Life  in  Portugal:  This  initiative  is  here  to  stay.  Rev  Port
ngiography  in  accordance  with  the  relevant  guidelines.  The
ask  Force  aims  to  implement  a  national  strategy  to  provide
-PCI  to  all  STEMI  patients,  discouraging  fibrinolysis  when-
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hospital.  If  a  STEMI  patient  presents  at  a  hospital  unable  to
provide  p-PCI,  CODU  should  be  contacted  immediately  and
asked:  ‘‘Can  this  patient  be  treated  by  p-PCI  in  less  than
120  min?’’  Fibrinolysis  should  only  be  performed  if  the
answer  is  negative.  In  either  case,  INEM  should  immedi-
ately  transfer  the  patient  to  a  24/7  p-PCI  center  to  perform
further  coronary  angiography,  pharmacoinvasive  therapy  or
rescue  angioplasty.
The  present  study,  designated  Moment  One,  was  carried
out  exactly  one  year  after  Moment  Zero  and  sought  to  eval-
uate  the  progress  of  Portuguese  performance  indicators  for
p-PCI  one  year  after  joining  the  SFL  initiative.
Improvements  were  observed  in  key  performance  indica-
tors,  such  as  an  increase  in  the  number  of  patients  using  the
national  medical  emergency  number  (112)  to  call  for  assis-
tance,  from  33%  in  2011  to  38%  in  2012.  From  the  available
data  it  is  not  possible  to  determine  whether  this  outcome  is
a  direct  result  of  the  SFL  campaign;  in  order  to  be  effective,
such  campaigns  should  be  prolonged  and  persistent.15 More-
over,  there  are  limitations  to  the  availability  of  the  INEM
service,  and  patients  may  therefore  be  referred  to  other
means  of  transportation.  However,  improvements  were  also
observed  in  this  aspect,  since  the  number  of  STEMI  patients
transported  by  INEM  increased  from  13%  at  Moment  Zero  to
37%  at  Moment  One.
Another  important  change  is  the  fall  in  the  number  of
patients  initially  arriving  at  hospitals  without  p-PCI,  from
62%  to  47%.  Additionally,  INEM  began  to  provide  inter-
hospital  secondary  transportation,  which  accounted  for  31%
at  Moment  One.  This  new  approach  to  inter-hospital  patient
transfer  is  intended  by  the  SFL  to  be  widened  to  all  STEMI
patients,  to  provide  p-PCI,  pharmacoinvasive  therapy  or  res-
cue  angioplasty.
The  SFL  initiative  aims  not  only  to  increase  the  number
of  patients  treated  by  p-PCI  in  Portugal,  but  also  to  improve
the  quality  of  such  therapy.  In  this  context,  delays  between
symptom  onset  and  use  of  first  device  in  the  culprit  artery
are  excellent  quality  indicators.16
The  most  notable  improvement  was  observed  in  patient
delay,  which  decreased  from  118  min  at  Moment  Zero  to
112  min  at  Moment  One.  In  particular,  a  greater  number  of
patients  reached  FMC  within  one  hour  of  the  first  symptom
(23%  vs.  35%).
Treatment  delay  did  not  change  significantly  between  the
two  time  points  (262  min  at  Moment  Zero,  and  250  min
at  Moment  One),  and  no  significant  differences  were  found
in  system  delay  (115  min  at  Moment  Zero,  and  127  min  at
Moment  One),  or  for  time  between  FMC  and  ECG.
The  essential  role  of  INEM  in  STEMI  patient  care  was
highlighted  by  significantly  shorter  treatment  delay  when
transportation  to  a  p-PCI  hospital  was  carried  out  by  INEM
(211  min  vs.  267  min  for  patients  arriving  at  the  hospital
by  other  means).  Transportation  by  INEM  is  associated  not
only  with  reduced  pre-hospital  transport  times,  but  also
with  shorter  patient  delay  and  system  delay.  The  increase
in  median  pre-hospital  transport  time  observed  at  Moment
One  was  due  to  the  implementation  of  inter-hospital  trans-
fer  by  INEM.  Patients  transferred  from  centers  without  p-PCIPlease  cite  this  article  in  press  as:  Pereira  H,  et  al.  Stent  for
Cardiol.  2014.  http://dx.doi.org/10.1016/j.repc.2014.02.013
to  hospitals  with  interventional  cardiology  units  presented
longer  times  than  recommended  between  FMC  and  p-PCI








The  most  important  indicator  was  probably  the  fact  that
atients  arriving  at  a  local  hospital  without  an  interventional
ardiology  unit  spent  more  time  in  inter-hospital  trans-
er  (transportation  time:  109  min)  than  those  transported
irectly  to  a  p-PCI  hospital  by  INEM  (transportation  time:
1  min).  For  this  reason,  the  SFL  initiative  should  continue
nd  the  ‘‘Act  now.  Save  a  life’’  campaign  should  be  intensi-
ed.
As  previously  reported,12 this  study  demonstrates  again
hat  D2B  time  is  not  a good  performance  index.  Although
2B  times  (55  min  at  Moment  Zero  and  53  min  at  Moment
ne)  were  shorter  than  those  in  the  ESC  guidelines,17 they
o  not  reflect  the  very  long  treatment  delays  and  the  overall
erformance  of  p-PCI  in  Portugal.
The  latest  ESC  guidelines  state  that,  in  order  to  optimize
TEMI  treatment,  a hospital  network  should  be  implemented
nd  coordinated  with  pre-  and  inter-hospital  transportation
o  minimize  treatment  delays.17 According  to  these  guide-
ines,  systems  for  data  recording,  monitoring  and  quality
ontrol  should  also  be  implemented.
To  summarize,  one  year  after  implementation  of  the  SFL
nitiative  in  Portugal,  we  observed  a positive  impact,  with
reater  use  of  the  112  emergency  call  service  and  a  smaller
umber  of  patients  arriving  by  their  own  means  at  local  hos-
itals  without  p-PCI  facilities.  Patient  delay  was  identified
t  Moment  Zero  as  a major  barrier  to  p-PCI  performance.12
owever,  a  considerable  improvement  was  observed  in  this
rea,  indicating  that  the  SFL’s  public  awareness  campaign  is
rogressing  successfully  and  should  be  intensified.  Although
ystem  delays  are  similar  to  those  recommended  by  the
uidelines,  the  SFL  initiative  will  focus  next  year  on  further
mproving  overall  system  performance.
thical disclosures
rotection  of  human  and  animal  subjects.  The  authors
eclare  that  no  experiments  were  performed  on  humans  or
nimals  for  this  study.
onfidentiality  of  data.  The  authors  declare  that  they  have
ollowed  the  protocols  of  their  work  center  on  the  publica-
ion  of  patient  data.
ight  to  privacy  and  informed  consent.  The  authors  have
btained  the  written  informed  consent  of  the  patients  or
ubjects  mentioned  in  the  article.  The  corresponding  author
s  in  possession  of  this  document.
onflicts of interest
he  authors  have  no  conflicts  of  interest  to  declare.
ppendix A. Participants
ospital  Vila  Real  (Dr.  Henrique  Carvalho),  Hospital  Braga
Dr.  João  Costa),  Hospital  S.  João  (Dr.  João  Carlos  Silva),
ospital  Santo  António  (Dr.  Henrique  Carvalho),  Centro  Hos- Life  in  Portugal:  This  initiative  is  here  to  stay.  Rev  Port
italar  Vila  Nova  de  Gaia  (Dr.  Vasco  Gama  Fernandes),
ospital  de  Viseu  (Dr.  João  Pipa),  Centro  Hospitalar  de  Coim-
ra  (Dr.  Leitão  Marques),  Hospital  de  Leiria  (Dr.  João  Morais),



















Document downloaded from http://www.elsevier.pt, day 07/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. This early online article has been reviewed, accepted and posted on the Web before copyediting.ARTICLEEPC-477; No. of Pages 8
 
ospital  de  Santa  Maria  (Dr.  Pedro  Canas  da  Silva),  Hospi-
al  Santa  Cruz  (Dr.  Manuel  Almeida),  Hospital  da  CUF  (Dr.
ousa  Ramos),  Hospital  Pulido  Valente  (Dr.  Pedro  Cardoso),
ospital  de  Santa  Marta  (Dr.  Rui  Ferreira),  Hospital  Curry
abral  (Dr.  Luís  Mourão),  Hospital  Garcia  de  Orta  (Dr.  Hélder
ereira),  Hospital  Setúbal  (Dr.  Ricardo  Santos);  Hospital  de
vora  (Dr.  Lino  Patrício  e  Dr.  Renato  Fernandes),  H  de  Faro
Dr.  Victor  Brandão).
eferences
1. Widimsky P, Fajadet J, Danchin N, et al. ‘‘Stent 4 Life’’ targeting
PCI at all who will benefit the most. A joint project between
EAPCI, Euro-PCR, EUCOMED and the ESC Working Group on Acute
Cardiac Care. EuroIntervention. 2009;4:555--7.
2. Widimsky P, Wijns W, Kaifoszova Z. Stent for Life: how this
initiative began? EuroIntervention. 2012;8:P8--10.
3. Widimsky P, Wijns W, Fajadet J, et al. Reperfusion therapy for
ST elevation acute myocardial infarction in Europe: descrip-
tion of the current situation in 30 countries. Eur Heart J.
2010;31:943--57.
4. Kristensen SD, Fajadet J, Di Mario C, et al. Implementation of
primary angioplasty in Europe: stent for life initiative progress
report. EuroIntervention. 2012;8:35--42.
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